Alev SELEK, Mehmet SÖZEN, İlhan TARKUN, Berrin ÇETINARSLAN, Zeynep CANTÜRK, Emre GEZER, Yeşim Saliha GÜRBÜZ, Funda ÖZTÜRK

Paratiroid Adenomlarında Östrojen Reseptör-Alfa Ekspresyonu ve Patolojik ve Klinik Özellikler Arasındaki Korelasyon

Amaç: Primer hiperparatiroidizm hiperkalseminin en yaygın nedenidir. Primer hiperparatiroidizm postmenopozal kadınlarda belirgin bir artış gösterir. Bu çalışmada primer hiperparatiroidi tanısı alan hastaların paratiroid adenomlarında östrojen reseptör alfa (ERα) ekspresyonu ile preoperatif serum kalsiyum ve paratiroid hormon (PTH) düzeylerinin adenom ağırlığı arasındaki ilişkiyi değerlendirmeyi amaçladık. Gereç ve Yöntemler: Tersiyer hiperparatiroidizm, çift adenom, paratiroid hiperplazi ve paratiroid karsinomu tanısı alan hastalar hariç tutulduktan sonra toplam 50 hasta çalışmaya dâhil edildi. Paratiroid adenom tanısı bir patolog tarafından doğrulandı. Paratiroid adenomunun doğrulanmasından sonra immünohistokimyasal yöntemle ERα ekspresyonu değerlendirildi. Paratiroid adenomlarının patolojik özellikleri kaydedildi. Bulgular: Çalışmaya dâhil edilen hastalar çoğunlukla kadın ve menopoz sonrası dönemdedirler. Hiçbir paratiroid adenomu immünohistokimyasal boyamada ERα ekspresyonu göstermemiştir. Erkek hastaların ameliyat öncesi ortalama kalsiyum ve D vitamini düzeyleri kadınlara göre daha yüksekti (sırasıyla p = 0.026, p = 0.009). Menopoz ile ameliyat öncesi kalsiyum, D vitamini ve PTH arasında korelasyon yoktu. Ameliyat öncesi serum kalsiyum ve PTH düzeyleri ile adenom çapı ve adenom ağırlığı arasında güçlü bir korelasyon bulundu. Sonuç: Çalışmamızda PTH düzeyleri ile birlikte paratiroid adenom çapı ve preoperatif serum kalsiyum arasında istatistiksel olarak anlamlı pozitif güçlü korelasyon saptandı. Bu bulgu hastaların ameliyat öncesi klinik özelliklerinin adenom çapının öngörülmesinde yararlı olabileceğini düşündürmektedir. Bununla birlikte, adenom çapı ile anlamlı bir ilişkisi olabilecek serum kalsiyum ve PTH seviyesinin cut-off değerlerini belirlemek önemlidir.

Estrogen Receptor-Alpha Expression and The Correlation Between Pathologic and Clinical Features in Parathyroid Adenomas

Aim: Primary hyperparathyroidism is the most common cause of hypercalcemia. Primary hyperparathyroidism shows a marked increase in postmenopausal women.In this study, we aimed to evaluate the estrogen receptors alpha (ERα) expression in parathyroid adenomas and the association of preoperative serum calcium and parathyroid hormone (PTH) levels with adenoma weight of patients diagnosed with primary hyperparathyroidism. Material and Methods: Total of 50 patients were included in the study, after excluding the patients diagnosed with tertiary hyperparathyroidism, double adenoma, parathyroid hyperplasia and parathyroid carcinoma. The diagnosis of parathyroid adenoma was confirmed by pathologist. After validation of parathyroid adenoma, ERα expression was evaluated with immunohistochemical method. Pathological features of the parathyroid adenomas were recorded. Results: The patients included in the study are mostly women and are in the postmenopausal period. Parathyroid adenoma hasn’t shown ERα expression in immunohistochemical staining. Male patients had higher mean pre-operative calcium and vitamin D levels than women (p=0.026, p=0.009 respectively). There was no correlation between menopause and pre-postoperative calcium, vitamin D and PTH. Correlation was found between adenoma diameter and adenoma weight with pre-operative serum calcium and PTH levels. Conclusion: In our study, statistically significant positive correlation was detected between the diameter of parathyroid adenoma and preoperative serum calcium together with PTH levels. This finding suggests the preoperative clinical features of the patients may be useful in predicting the adenoma diameter. However, it is important to determine the cut-off values of serum calcium and PTH level which might have a significant association with the adenoma diameter.

PDF

___

1. O’Connor C., Levine J.A., Hahr A. Primary Hyperparathyroidism. In: Camacho P. (ed.) Metabolic Bone Diseases. Springer. 2019, 15-25.
2. Cetani F, Marcocci F. Parathyroid Carcinoma. In: John P. Bilezikian (ed.), The Parathyroids (Third Edition), Academic Press, 2015, 409-421.
3. Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018 J;391(10116):168-178.
4. Haglund F, Ma R, Huss M, Sulaiman L, Lu M, Nilsson IL, et al. Evidence of a functional estrogen receptor in parathyroid adenomas. J Clin Endocrinol Metab. 2012;97(12):4631- 4639.
5. Farford B, Presutti RJ, Moraghan TJ. Nonsurgical management of primary hyperparathyroidism. Mayo Clin Proc. 2007;82(3):351-355.
6. Greenberg C, Kukreja SC, Bowser EN, Hargis GK, Henderson WJ, Williams GA. Parathyroid hormone secretion: Effect of estradiol and progesterone. Metabolism. 1987;36(2):151-154.
7. Nilsson S, Koehler KF, Gustafsson JÅ. Development of subtype-selective oestrogen receptor-based therapeutics. Nat Rev Drug Discov. 2011;10(10):778-792.
8. Bindlish V, Freeman JL, Witterick IJ, Asa SL. Correlation of biochemical parameters with single parathyroid adenoma weight and volume. Head Neck. 2002;24(11):1000-1003.
9. Wagner PK, Rothmund M. Correlation of tumor weight and typical pathologic laboratory parameters in primary and secondary hyperparathyroidism. Langenbecks Arch Chir. 1983;360(2):133-139.
10. Saadeh G, Licata AA, Esselstyn C, Gupta M. Relationship of parathyroid adenoma volume and biochemical function. Horm Res Paediatr. 1989;32(4):142-144.
11. F. Richard Bringhurst, Demay MB, Kronenberg HM. Hormones and Disorders of Mineral Metabolism. In: Melmed S, Polonsky K, Larsen PR, Kronenberg H (eds). Williams Textbook of Endocrinology. 12th ed. Elsevier Sanders Publications; 2011, 1237-1304.
12. Prince RL, Maclaughlin DT, Gaz RD, Neer RM. Lack of evidence for estrogen receptors in human and bovine parathyroid tissue. J Clin Endocrinol Metab. 1991;72(6):1226-1228.
13. Saxe AW, Gibson GW, Russo IH, Gimotty P. Measurement of estrogen and progesterone receptors in abnormal human parathyroid tissue. Calcif Tissue Int. 1992;51(5):344-347.
14. Carrillo-López N, Román-García P, Rodríguez-Rebollar A, Fernández-Martín JL, Naves-Díaz M, Cannata-Andía JB. Indirect regulation of PTH by estrogens may require FGF23. J Am Soc Nephrol. 2009;20(9):2009-2017.
15. Mazeh H, Sippel RS, Chen H. The role of gender in primary hyperparathyroidism: Same disease, different presentation. Ann Surg Oncol. 2012;19(9):2958-2962.
16. Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR, Bhavin V. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism. J Postgrad Med. 2012;58(2):107-111.
17. Cigerli O, Parildar H, Unal AD, Tarcin O, Erdal R, Guvener Demirag N. Vitamin D deficiency is a problem for adult outpatients? A university hospital sample in Istanbul, Turkey. Public Health Nutr. 2013;16(7):1306-1313.
18. Moretz WH, Watts TL, Virgin FW, Chin E, Gourin CG, Terris DJ. Correlation of intraoperative parathyroid hormone levels with parathyroid gland size. Laryngoscope. 2007;117(11):1957-1960.
19. Kebebew E, Hwang J, Reiff E, Duh QY, Clark OH. Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: A simple and accurate scoring model. Arch Surg. 2006;141(8):777-782.
20. Williams JG, Wheeler MH, Aston JP, Brown RC, Woodhead JS. The relationship between adenoma weight and intact (1-84) parathyroid hormone level in primary hyperparathyroidism. Am J Surg. 1992;163(3):301-304.
21. Hamidi S, Aslani A, Nakhjavani M, Pajouhi M, Hedayat A, Kamalian N. Are biochemical values predictive of adenoma’s weight in primary hyperparathyroidism? ANZ J Surg. 2006;76(10):882-885.
22. Cetani F, Picone A, Cerrai P, Vignali E, Borsari S, Pardi E, et al. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) setpoint in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2000;85(12):4789-4794.
23. Mun HC, Conigrave A, Wilkinson M, Delbridge L, Duh QY, Delbridge L. Surgery for hyperparathyroidism: Does morphology or function matter most? Surgery. 2005;138(6):1111-1120.